beta-catenin regulates NF-kappa B activity via TNFRSF19 in colorectal cancer cells

Wnt/beta-catenin signaling plays a crucial role in the regulation of colon tissue regeneration and the development of colon tumors. Under physiological conditions, beta-catenin activity is tightly controlled. However, the majority of sporadic forms of colorectal cancer are characterized by inactivation of the tumor suppressor gene APC due to loss of heterozygosity ( LOH), resulting in deregulation of the protein beta-catenin. Apart from known beta-catenin target genes like MYC, OPG, and DKK4, the gene TNFRSF19, a member of the TNF receptor superfamily, is regulated by beta-catenin in mesenchymal stem cells ( hMSC). We found that TNFRSF19 is frequently overexpressed in colorectal cancer cell lines and primary colorectal carcinomas. Further characterization revealed that both isoforms of TNFRSF19, TNFRSF19.1 and TNFRSF19.2, are regulated in a beta-catenin dependent manner. The transcript TNFRSF19.2 encodes a 417 amino acid long protein containing a TRAF-binding site that links the TNFRSF19.2 to NF-kappa B signaling, whereas the isoform TNFRSF19.1 lacks this TRAF-binding site. Nevertheless both isoform 1 and 2 induced the activity of an NF-kappa B reporter gene. NF-kappa B signaling is important for inflammatory processes and chronic inflammatory diseases like ulcerative colitis and Crohn's disease, which are associated with increased risk for developing colorectal cancer. The observation that TNFRSF19 is a beta-catenin target gene and TNFRSF19 receptor molecules activate NF-kappa B signaling shows that beta-catenin regulates NF-kappa B activity via TNFRSF19, suggesting that TNFRSF19 may contribute to the development of colorectal tumors with deregulated beta-catenin activity